Samsung Bioepis’ biosimilars Ospomyv and Xbryk have been approved to be interchangeable with Prolia/Xgeva treat osteoporosis ...
Dr. Reddy’s has entered into a license agreement with Shanghai Henlius Biotech related to the development and ...
A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...
Born on November 4, 1941, in Brooklyn, New York, Rose Marie was the daughter of the late Joseph and Mary (Sepulveres) Arioso.
Cilta-cel enables sustained MRD negativity in patients with previously treated MM, according to results from the CARTITUDE-4 trial.
Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for OS ...
"Find joy in all circumstances," the late David Bauer said, quoting Apostle Paul in the Bible. He did that even as he fought multiple myeloma for five years.
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...
The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...
The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision ...
Health on MSN3d
Is Multiple Myeloma Hereditary?Medically reviewed by Marla Anderson, MD Multiple myeloma is a type of blood cancer that forms in plasma cells, white blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback